nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP1A2—Estropipate—osteoporosis	0.123	0.192	CbGbCtD
Palonosetron—CYP3A4—Estropipate—osteoporosis	0.0644	0.101	CbGbCtD
Palonosetron—CYP3A4—Calcitriol—osteoporosis	0.0644	0.101	CbGbCtD
Palonosetron—CYP1A2—Conjugated Estrogens—osteoporosis	0.0581	0.0909	CbGbCtD
Palonosetron—CYP2D6—Cholecalciferol—osteoporosis	0.0521	0.0816	CbGbCtD
Palonosetron—CYP3A4—Ergocalciferol—osteoporosis	0.0515	0.0805	CbGbCtD
Palonosetron—CYP1A2—Estradiol—osteoporosis	0.051	0.0798	CbGbCtD
Palonosetron—CYP3A4—Raloxifene—osteoporosis	0.0429	0.0672	CbGbCtD
Palonosetron—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0415	0.0649	CbGbCtD
Palonosetron—CYP3A4—Cholecalciferol—osteoporosis	0.0332	0.0519	CbGbCtD
Palonosetron—CYP3A4—Conjugated Estrogens—osteoporosis	0.0304	0.0476	CbGbCtD
Palonosetron—CYP3A4—Estradiol—osteoporosis	0.0267	0.0418	CbGbCtD
Palonosetron—Abdominal pain—Calcitriol—osteoporosis	0.000411	0.00114	CcSEcCtD
Palonosetron—Body temperature increased—Calcitriol—osteoporosis	0.000411	0.00114	CcSEcCtD
Palonosetron—Shock—Pamidronate—osteoporosis	0.000409	0.00113	CcSEcCtD
Palonosetron—Hypersensitivity—Estropipate—osteoporosis	0.000408	0.00113	CcSEcCtD
Palonosetron—Nervous system disorder—Pamidronate—osteoporosis	0.000408	0.00113	CcSEcCtD
Palonosetron—Urinary tract disorder—Estradiol—osteoporosis	0.000407	0.00113	CcSEcCtD
Palonosetron—Vomiting—Etidronic acid—osteoporosis	0.000407	0.00113	CcSEcCtD
Palonosetron—Tachycardia—Pamidronate—osteoporosis	0.000406	0.00112	CcSEcCtD
Palonosetron—Connective tissue disorder—Estradiol—osteoporosis	0.000405	0.00112	CcSEcCtD
Palonosetron—Urethral disorder—Estradiol—osteoporosis	0.000404	0.00112	CcSEcCtD
Palonosetron—Rash—Etidronic acid—osteoporosis	0.000403	0.00112	CcSEcCtD
Palonosetron—Convulsion—Zoledronate—osteoporosis	0.000403	0.00112	CcSEcCtD
Palonosetron—Dermatitis—Etidronic acid—osteoporosis	0.000403	0.00112	CcSEcCtD
Palonosetron—Hypertension—Zoledronate—osteoporosis	0.000402	0.00111	CcSEcCtD
Palonosetron—Hypersensitivity—Alendronate—osteoporosis	0.000402	0.00111	CcSEcCtD
Palonosetron—Headache—Etidronic acid—osteoporosis	0.000401	0.00111	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000399	0.0011	CcSEcCtD
Palonosetron—Asthenia—Estropipate—osteoporosis	0.000397	0.0011	CcSEcCtD
Palonosetron—Anorexia—Pamidronate—osteoporosis	0.000396	0.0011	CcSEcCtD
Palonosetron—Myalgia—Zoledronate—osteoporosis	0.000396	0.0011	CcSEcCtD
Palonosetron—Arthralgia—Zoledronate—osteoporosis	0.000396	0.0011	CcSEcCtD
Palonosetron—Insomnia—Risedronate—osteoporosis	0.000396	0.0011	CcSEcCtD
Palonosetron—Anxiety—Zoledronate—osteoporosis	0.000395	0.00109	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000394	0.00109	CcSEcCtD
Palonosetron—Paraesthesia—Risedronate—osteoporosis	0.000393	0.00109	CcSEcCtD
Palonosetron—Pruritus—Estropipate—osteoporosis	0.000392	0.00109	CcSEcCtD
Palonosetron—Discomfort—Zoledronate—osteoporosis	0.000392	0.00108	CcSEcCtD
Palonosetron—Asthenia—Alendronate—osteoporosis	0.000391	0.00108	CcSEcCtD
Palonosetron—Hypersensitivity—Ibandronate—osteoporosis	0.000391	0.00108	CcSEcCtD
Palonosetron—Dyspnoea—Risedronate—osteoporosis	0.00039	0.00108	CcSEcCtD
Palonosetron—Hypotension—Pamidronate—osteoporosis	0.000389	0.00108	CcSEcCtD
Palonosetron—Convulsion—Conjugated Estrogens—osteoporosis	0.000388	0.00108	CcSEcCtD
Palonosetron—Dry mouth—Zoledronate—osteoporosis	0.000388	0.00107	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000387	0.00107	CcSEcCtD
Palonosetron—Fatigue—Ethinyl Estradiol—osteoporosis	0.000387	0.00107	CcSEcCtD
Palonosetron—Pruritus—Alendronate—osteoporosis	0.000386	0.00107	CcSEcCtD
Palonosetron—Dyspepsia—Risedronate—osteoporosis	0.000385	0.00107	CcSEcCtD
Palonosetron—Eye disorder—Estradiol—osteoporosis	0.000385	0.00107	CcSEcCtD
Palonosetron—Tinnitus—Estradiol—osteoporosis	0.000384	0.00106	CcSEcCtD
Palonosetron—Constipation—Ethinyl Estradiol—osteoporosis	0.000384	0.00106	CcSEcCtD
Palonosetron—Hypersensitivity—Calcitriol—osteoporosis	0.000383	0.00106	CcSEcCtD
Palonosetron—Cardiac disorder—Estradiol—osteoporosis	0.000382	0.00106	CcSEcCtD
Palonosetron—Arthralgia—Conjugated Estrogens—osteoporosis	0.000382	0.00106	CcSEcCtD
Palonosetron—Myalgia—Conjugated Estrogens—osteoporosis	0.000382	0.00106	CcSEcCtD
Palonosetron—Asthenia—Ibandronate—osteoporosis	0.000381	0.00106	CcSEcCtD
Palonosetron—Anxiety—Conjugated Estrogens—osteoporosis	0.00038	0.00105	CcSEcCtD
Palonosetron—Nausea—Etidronic acid—osteoporosis	0.00038	0.00105	CcSEcCtD
Palonosetron—Anaphylactic shock—Zoledronate—osteoporosis	0.00038	0.00105	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000379	0.00105	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000379	0.00105	CcSEcCtD
Palonosetron—Diarrhoea—Estropipate—osteoporosis	0.000379	0.00105	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Risedronate—osteoporosis	0.000378	0.00105	CcSEcCtD
Palonosetron—Infection—Zoledronate—osteoporosis	0.000377	0.00105	CcSEcCtD
Palonosetron—Fatigue—Risedronate—osteoporosis	0.000377	0.00104	CcSEcCtD
Palonosetron—Insomnia—Pamidronate—osteoporosis	0.000376	0.00104	CcSEcCtD
Palonosetron—Pruritus—Ibandronate—osteoporosis	0.000376	0.00104	CcSEcCtD
Palonosetron—Constipation—Risedronate—osteoporosis	0.000374	0.00104	CcSEcCtD
Palonosetron—Pain—Risedronate—osteoporosis	0.000374	0.00104	CcSEcCtD
Palonosetron—Angiopathy—Estradiol—osteoporosis	0.000374	0.00104	CcSEcCtD
Palonosetron—Shock—Zoledronate—osteoporosis	0.000374	0.00104	CcSEcCtD
Palonosetron—Paraesthesia—Pamidronate—osteoporosis	0.000373	0.00103	CcSEcCtD
Palonosetron—Diarrhoea—Alendronate—osteoporosis	0.000373	0.00103	CcSEcCtD
Palonosetron—Asthenia—Calcitriol—osteoporosis	0.000373	0.00103	CcSEcCtD
Palonosetron—Nervous system disorder—Zoledronate—osteoporosis	0.000373	0.00103	CcSEcCtD
Palonosetron—Immune system disorder—Estradiol—osteoporosis	0.000372	0.00103	CcSEcCtD
Palonosetron—Mediastinal disorder—Estradiol—osteoporosis	0.000371	0.00103	CcSEcCtD
Palonosetron—Dyspnoea—Pamidronate—osteoporosis	0.000371	0.00103	CcSEcCtD
Palonosetron—Tachycardia—Zoledronate—osteoporosis	0.000371	0.00103	CcSEcCtD
Palonosetron—Chills—Estradiol—osteoporosis	0.00037	0.00102	CcSEcCtD
Palonosetron—Somnolence—Pamidronate—osteoporosis	0.00037	0.00102	CcSEcCtD
Palonosetron—Skin disorder—Zoledronate—osteoporosis	0.000369	0.00102	CcSEcCtD
Palonosetron—Pruritus—Calcitriol—osteoporosis	0.000368	0.00102	CcSEcCtD
Palonosetron—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000367	0.00102	CcSEcCtD
Palonosetron—Diarrhoea—Raloxifene—osteoporosis	0.000367	0.00102	CcSEcCtD
Palonosetron—Dyspepsia—Pamidronate—osteoporosis	0.000366	0.00101	CcSEcCtD
Palonosetron—Dizziness—Estropipate—osteoporosis	0.000366	0.00101	CcSEcCtD
Palonosetron—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000366	0.00101	CcSEcCtD
Palonosetron—Alopecia—Estradiol—osteoporosis	0.000364	0.00101	CcSEcCtD
Palonosetron—Infection—Conjugated Estrogens—osteoporosis	0.000363	0.00101	CcSEcCtD
Palonosetron—Diarrhoea—Ibandronate—osteoporosis	0.000363	0.00101	CcSEcCtD
Palonosetron—Anorexia—Zoledronate—osteoporosis	0.000362	0.001	CcSEcCtD
Palonosetron—Decreased appetite—Pamidronate—osteoporosis	0.000362	0.001	CcSEcCtD
Palonosetron—Mental disorder—Estradiol—osteoporosis	0.000361	0.001	CcSEcCtD
Palonosetron—Dizziness—Alendronate—osteoporosis	0.000361	0.000999	CcSEcCtD
Palonosetron—Shock—Conjugated Estrogens—osteoporosis	0.00036	0.000997	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000359	0.000995	CcSEcCtD
Palonosetron—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000359	0.000994	CcSEcCtD
Palonosetron—Malnutrition—Estradiol—osteoporosis	0.000359	0.000994	CcSEcCtD
Palonosetron—Erythema—Estradiol—osteoporosis	0.000359	0.000994	CcSEcCtD
Palonosetron—Fatigue—Pamidronate—osteoporosis	0.000359	0.000993	CcSEcCtD
Palonosetron—Gastrointestinal pain—Risedronate—osteoporosis	0.000358	0.000991	CcSEcCtD
Palonosetron—Tachycardia—Conjugated Estrogens—osteoporosis	0.000357	0.000989	CcSEcCtD
Palonosetron—Pain—Pamidronate—osteoporosis	0.000356	0.000985	CcSEcCtD
Palonosetron—Constipation—Pamidronate—osteoporosis	0.000356	0.000985	CcSEcCtD
Palonosetron—Diarrhoea—Calcitriol—osteoporosis	0.000356	0.000985	CcSEcCtD
Palonosetron—Skin disorder—Conjugated Estrogens—osteoporosis	0.000355	0.000984	CcSEcCtD
Palonosetron—Hypotension—Zoledronate—osteoporosis	0.000355	0.000983	CcSEcCtD
Palonosetron—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000355	0.000983	CcSEcCtD
Palonosetron—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000355	0.000983	CcSEcCtD
Palonosetron—Dizziness—Raloxifene—osteoporosis	0.000355	0.000982	CcSEcCtD
Palonosetron—Flatulence—Estradiol—osteoporosis	0.000353	0.000979	CcSEcCtD
Palonosetron—Vomiting—Estropipate—osteoporosis	0.000352	0.000975	CcSEcCtD
Palonosetron—Dysgeusia—Estradiol—osteoporosis	0.000351	0.000973	CcSEcCtD
Palonosetron—Dizziness—Ibandronate—osteoporosis	0.000351	0.000973	CcSEcCtD
Palonosetron—Rash—Estropipate—osteoporosis	0.000349	0.000967	CcSEcCtD
Palonosetron—Dermatitis—Estropipate—osteoporosis	0.000349	0.000966	CcSEcCtD
Palonosetron—Anorexia—Conjugated Estrogens—osteoporosis	0.000349	0.000966	CcSEcCtD
Palonosetron—Headache—Estropipate—osteoporosis	0.000347	0.000961	CcSEcCtD
Palonosetron—Vomiting—Alendronate—osteoporosis	0.000347	0.00096	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000346	0.000959	CcSEcCtD
Palonosetron—Abdominal pain—Risedronate—osteoporosis	0.000346	0.000958	CcSEcCtD
Palonosetron—Body temperature increased—Risedronate—osteoporosis	0.000346	0.000958	CcSEcCtD
Palonosetron—Rash—Alendronate—osteoporosis	0.000344	0.000952	CcSEcCtD
Palonosetron—Insomnia—Zoledronate—osteoporosis	0.000344	0.000952	CcSEcCtD
Palonosetron—Dermatitis—Alendronate—osteoporosis	0.000343	0.000952	CcSEcCtD
Palonosetron—Hypotension—Conjugated Estrogens—osteoporosis	0.000342	0.000947	CcSEcCtD
Palonosetron—Headache—Alendronate—osteoporosis	0.000342	0.000946	CcSEcCtD
Palonosetron—Paraesthesia—Zoledronate—osteoporosis	0.000341	0.000945	CcSEcCtD
Palonosetron—Vomiting—Raloxifene—osteoporosis	0.000341	0.000945	CcSEcCtD
Palonosetron—Gastrointestinal pain—Pamidronate—osteoporosis	0.00034	0.000942	CcSEcCtD
Palonosetron—Dyspnoea—Zoledronate—osteoporosis	0.000339	0.000938	CcSEcCtD
Palonosetron—Rash—Raloxifene—osteoporosis	0.000338	0.000937	CcSEcCtD
Palonosetron—Dermatitis—Raloxifene—osteoporosis	0.000338	0.000936	CcSEcCtD
Palonosetron—Somnolence—Zoledronate—osteoporosis	0.000338	0.000936	CcSEcCtD
Palonosetron—Vomiting—Ibandronate—osteoporosis	0.000338	0.000935	CcSEcCtD
Palonosetron—Headache—Raloxifene—osteoporosis	0.000336	0.000931	CcSEcCtD
Palonosetron—Rash—Ibandronate—osteoporosis	0.000335	0.000927	CcSEcCtD
Palonosetron—Dermatitis—Ibandronate—osteoporosis	0.000334	0.000926	CcSEcCtD
Palonosetron—Dyspepsia—Zoledronate—osteoporosis	0.000334	0.000926	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000333	0.000923	CcSEcCtD
Palonosetron—Headache—Ibandronate—osteoporosis	0.000333	0.000921	CcSEcCtD
Palonosetron—Insomnia—Conjugated Estrogens—osteoporosis	0.000331	0.000917	CcSEcCtD
Palonosetron—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000331	0.000916	CcSEcCtD
Palonosetron—Vomiting—Calcitriol—osteoporosis	0.00033	0.000915	CcSEcCtD
Palonosetron—Decreased appetite—Zoledronate—osteoporosis	0.00033	0.000915	CcSEcCtD
Palonosetron—Nausea—Estropipate—osteoporosis	0.000329	0.000911	CcSEcCtD
Palonosetron—Abdominal pain—Pamidronate—osteoporosis	0.000329	0.000911	CcSEcCtD
Palonosetron—Body temperature increased—Pamidronate—osteoporosis	0.000329	0.000911	CcSEcCtD
Palonosetron—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000328	0.00091	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000328	0.000909	CcSEcCtD
Palonosetron—Rash—Calcitriol—osteoporosis	0.000328	0.000908	CcSEcCtD
Palonosetron—Fatigue—Zoledronate—osteoporosis	0.000328	0.000907	CcSEcCtD
Palonosetron—Dermatitis—Calcitriol—osteoporosis	0.000327	0.000907	CcSEcCtD
Palonosetron—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000326	0.000904	CcSEcCtD
Palonosetron—Headache—Calcitriol—osteoporosis	0.000326	0.000902	CcSEcCtD
Palonosetron—Somnolence—Conjugated Estrogens—osteoporosis	0.000325	0.000901	CcSEcCtD
Palonosetron—Constipation—Zoledronate—osteoporosis	0.000325	0.0009	CcSEcCtD
Palonosetron—Pain—Zoledronate—osteoporosis	0.000325	0.0009	CcSEcCtD
Palonosetron—Nausea—Alendronate—osteoporosis	0.000324	0.000897	CcSEcCtD
Palonosetron—Hypersensitivity—Risedronate—osteoporosis	0.000322	0.000893	CcSEcCtD
Palonosetron—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000322	0.000892	CcSEcCtD
Palonosetron—Asthenia—Ethinyl Estradiol—osteoporosis	0.000322	0.000892	CcSEcCtD
Palonosetron—Nausea—Raloxifene—osteoporosis	0.000319	0.000882	CcSEcCtD
Palonosetron—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000318	0.000881	CcSEcCtD
Palonosetron—Pruritus—Ethinyl Estradiol—osteoporosis	0.000317	0.00088	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000316	0.000875	CcSEcCtD
Palonosetron—Fatigue—Conjugated Estrogens—osteoporosis	0.000315	0.000874	CcSEcCtD
Palonosetron—Nausea—Ibandronate—osteoporosis	0.000315	0.000874	CcSEcCtD
Palonosetron—Asthenia—Risedronate—osteoporosis	0.000314	0.00087	CcSEcCtD
Palonosetron—Pain—Conjugated Estrogens—osteoporosis	0.000313	0.000867	CcSEcCtD
Palonosetron—Constipation—Conjugated Estrogens—osteoporosis	0.000313	0.000867	CcSEcCtD
Palonosetron—Gastrointestinal pain—Zoledronate—osteoporosis	0.000311	0.000861	CcSEcCtD
Palonosetron—Hypertension—Estradiol—osteoporosis	0.00031	0.000858	CcSEcCtD
Palonosetron—Pruritus—Risedronate—osteoporosis	0.00031	0.000858	CcSEcCtD
Palonosetron—Nausea—Calcitriol—osteoporosis	0.000309	0.000855	CcSEcCtD
Palonosetron—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000307	0.000851	CcSEcCtD
Palonosetron—Hypersensitivity—Pamidronate—osteoporosis	0.000306	0.000849	CcSEcCtD
Palonosetron—Arthralgia—Estradiol—osteoporosis	0.000305	0.000846	CcSEcCtD
Palonosetron—Myalgia—Estradiol—osteoporosis	0.000305	0.000846	CcSEcCtD
Palonosetron—Anxiety—Estradiol—osteoporosis	0.000304	0.000843	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000303	0.00084	CcSEcCtD
Palonosetron—Discomfort—Estradiol—osteoporosis	0.000302	0.000836	CcSEcCtD
Palonosetron—Body temperature increased—Zoledronate—osteoporosis	0.0003	0.000832	CcSEcCtD
Palonosetron—Abdominal pain—Zoledronate—osteoporosis	0.0003	0.000832	CcSEcCtD
Palonosetron—Diarrhoea—Risedronate—osteoporosis	0.000299	0.000829	CcSEcCtD
Palonosetron—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000299	0.000829	CcSEcCtD
Palonosetron—Dry mouth—Estradiol—osteoporosis	0.000299	0.000827	CcSEcCtD
Palonosetron—Asthenia—Pamidronate—osteoporosis	0.000298	0.000827	CcSEcCtD
Palonosetron—Dizziness—Ethinyl Estradiol—osteoporosis	0.000297	0.000822	CcSEcCtD
Palonosetron—Pruritus—Pamidronate—osteoporosis	0.000294	0.000815	CcSEcCtD
Palonosetron—Anaphylactic shock—Estradiol—osteoporosis	0.000293	0.000811	CcSEcCtD
Palonosetron—Infection—Estradiol—osteoporosis	0.000291	0.000806	CcSEcCtD
Palonosetron—Dizziness—Risedronate—osteoporosis	0.000289	0.000802	CcSEcCtD
Palonosetron—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000289	0.000801	CcSEcCtD
Palonosetron—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000289	0.000801	CcSEcCtD
Palonosetron—Shock—Estradiol—osteoporosis	0.000288	0.000798	CcSEcCtD
Palonosetron—Nervous system disorder—Estradiol—osteoporosis	0.000287	0.000795	CcSEcCtD
Palonosetron—Tachycardia—Estradiol—osteoporosis	0.000286	0.000792	CcSEcCtD
Palonosetron—Vomiting—Ethinyl Estradiol—osteoporosis	0.000285	0.00079	CcSEcCtD
Palonosetron—Diarrhoea—Pamidronate—osteoporosis	0.000285	0.000788	CcSEcCtD
Palonosetron—Skin disorder—Estradiol—osteoporosis	0.000284	0.000788	CcSEcCtD
Palonosetron—Rash—Ethinyl Estradiol—osteoporosis	0.000283	0.000784	CcSEcCtD
Palonosetron—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000283	0.000783	CcSEcCtD
Palonosetron—Headache—Ethinyl Estradiol—osteoporosis	0.000281	0.000779	CcSEcCtD
Palonosetron—Hypersensitivity—Zoledronate—osteoporosis	0.00028	0.000775	CcSEcCtD
Palonosetron—Vomiting—Risedronate—osteoporosis	0.000278	0.000771	CcSEcCtD
Palonosetron—Rash—Risedronate—osteoporosis	0.000276	0.000764	CcSEcCtD
Palonosetron—Dermatitis—Risedronate—osteoporosis	0.000276	0.000764	CcSEcCtD
Palonosetron—Dizziness—Pamidronate—osteoporosis	0.000275	0.000762	CcSEcCtD
Palonosetron—Headache—Risedronate—osteoporosis	0.000274	0.000759	CcSEcCtD
Palonosetron—Asthenia—Zoledronate—osteoporosis	0.000273	0.000755	CcSEcCtD
Palonosetron—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00027	0.000747	CcSEcCtD
Palonosetron—Pruritus—Zoledronate—osteoporosis	0.000269	0.000745	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000267	0.000739	CcSEcCtD
Palonosetron—Nausea—Ethinyl Estradiol—osteoporosis	0.000267	0.000738	CcSEcCtD
Palonosetron—Insomnia—Estradiol—osteoporosis	0.000265	0.000734	CcSEcCtD
Palonosetron—Vomiting—Pamidronate—osteoporosis	0.000264	0.000733	CcSEcCtD
Palonosetron—Paraesthesia—Estradiol—osteoporosis	0.000263	0.000728	CcSEcCtD
Palonosetron—Asthenia—Conjugated Estrogens—osteoporosis	0.000262	0.000727	CcSEcCtD
Palonosetron—Rash—Pamidronate—osteoporosis	0.000262	0.000726	CcSEcCtD
Palonosetron—Dermatitis—Pamidronate—osteoporosis	0.000262	0.000726	CcSEcCtD
Palonosetron—Dyspnoea—Estradiol—osteoporosis	0.000261	0.000723	CcSEcCtD
Palonosetron—Headache—Pamidronate—osteoporosis	0.000261	0.000722	CcSEcCtD
Palonosetron—Somnolence—Estradiol—osteoporosis	0.00026	0.000721	CcSEcCtD
Palonosetron—Diarrhoea—Zoledronate—osteoporosis	0.00026	0.00072	CcSEcCtD
Palonosetron—Nausea—Risedronate—osteoporosis	0.00026	0.00072	CcSEcCtD
Palonosetron—Pruritus—Conjugated Estrogens—osteoporosis	0.000259	0.000717	CcSEcCtD
Palonosetron—Dyspepsia—Estradiol—osteoporosis	0.000258	0.000714	CcSEcCtD
Palonosetron—Decreased appetite—Estradiol—osteoporosis	0.000254	0.000705	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Estradiol—osteoporosis	0.000253	0.0007	CcSEcCtD
Palonosetron—Fatigue—Estradiol—osteoporosis	0.000252	0.000699	CcSEcCtD
Palonosetron—Dizziness—Zoledronate—osteoporosis	0.000251	0.000696	CcSEcCtD
Palonosetron—Pain—Estradiol—osteoporosis	0.00025	0.000694	CcSEcCtD
Palonosetron—Constipation—Estradiol—osteoporosis	0.00025	0.000694	CcSEcCtD
Palonosetron—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00025	0.000693	CcSEcCtD
Palonosetron—Nausea—Pamidronate—osteoporosis	0.000247	0.000684	CcSEcCtD
Palonosetron—Dizziness—Conjugated Estrogens—osteoporosis	0.000242	0.00067	CcSEcCtD
Palonosetron—Vomiting—Zoledronate—osteoporosis	0.000242	0.000669	CcSEcCtD
Palonosetron—Rash—Zoledronate—osteoporosis	0.00024	0.000664	CcSEcCtD
Palonosetron—Gastrointestinal pain—Estradiol—osteoporosis	0.000239	0.000663	CcSEcCtD
Palonosetron—Dermatitis—Zoledronate—osteoporosis	0.000239	0.000663	CcSEcCtD
Palonosetron—Headache—Zoledronate—osteoporosis	0.000238	0.000659	CcSEcCtD
Palonosetron—Vomiting—Conjugated Estrogens—osteoporosis	0.000233	0.000644	CcSEcCtD
Palonosetron—Abdominal pain—Estradiol—osteoporosis	0.000231	0.000641	CcSEcCtD
Palonosetron—Body temperature increased—Estradiol—osteoporosis	0.000231	0.000641	CcSEcCtD
Palonosetron—Rash—Conjugated Estrogens—osteoporosis	0.000231	0.000639	CcSEcCtD
Palonosetron—Dermatitis—Conjugated Estrogens—osteoporosis	0.00023	0.000638	CcSEcCtD
Palonosetron—Headache—Conjugated Estrogens—osteoporosis	0.000229	0.000635	CcSEcCtD
Palonosetron—Nausea—Zoledronate—osteoporosis	0.000226	0.000625	CcSEcCtD
Palonosetron—Nausea—Conjugated Estrogens—osteoporosis	0.000217	0.000602	CcSEcCtD
Palonosetron—Hypersensitivity—Estradiol—osteoporosis	0.000216	0.000598	CcSEcCtD
Palonosetron—Asthenia—Estradiol—osteoporosis	0.00021	0.000582	CcSEcCtD
Palonosetron—Pruritus—Estradiol—osteoporosis	0.000207	0.000574	CcSEcCtD
Palonosetron—Diarrhoea—Estradiol—osteoporosis	0.0002	0.000555	CcSEcCtD
Palonosetron—Dizziness—Estradiol—osteoporosis	0.000194	0.000536	CcSEcCtD
Palonosetron—Vomiting—Estradiol—osteoporosis	0.000186	0.000516	CcSEcCtD
Palonosetron—Rash—Estradiol—osteoporosis	0.000185	0.000511	CcSEcCtD
Palonosetron—Dermatitis—Estradiol—osteoporosis	0.000184	0.000511	CcSEcCtD
Palonosetron—Headache—Estradiol—osteoporosis	0.000183	0.000508	CcSEcCtD
Palonosetron—Nausea—Estradiol—osteoporosis	0.000174	0.000482	CcSEcCtD
